<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01580163</url>
  </required_header>
  <id_info>
    <org_study_id>MZhao-002</org_study_id>
    <nct_id>NCT01580163</nct_id>
  </id_info>
  <brief_title>Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification</brief_title>
  <official_title>Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Mental Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Center of Biomedicine Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Mental Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to observe the efficacy of comprehensive treatment model to
      improve treatment compliance and relapse prevention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The model include the Chinese traditional medicine JITAI combined with psychological
      intervention and social support for maintenance therapy after acute detoxification of heroin
      addicts.On the basis of the existing community management experience and community of
      professional anti-drug community service，The investigator will adopt the Chinese traditional
      medicine JITAI combined with psychological intervention and social support for maintenance
      therapy after acute detoxification of the community of heroin addicts.The purpose is to
      observe the comprehensive treatment model to improve treatment compliance and relapse
      prevention，then the investigator will form a new model of community humane drug treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The drug use pattern during observation period</measure>
    <time_frame>Baseline ,26 weeks and 52 weeks</time_frame>
    <description>The investigator will ues NHI(Nature History Interview) to describe the drug use pattern and and compare the different change among different groups during observation period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of ASI(Addiction Severity Index) after the treatment and observation</measure>
    <time_frame>Baseline,26weeks and 52 weeks</time_frame>
    <description>The investigator will use ASI to describe the addiction severity of objects and compare the different change among different groups during observation period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the change of drug use pattern during observation period</measure>
    <time_frame>Baseline,26weeks and 52 weeks</time_frame>
    <description>The investigator will ues NHI(Nature History Interview) to describe the drug use pattern and and compare the different change among different groups during observation period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the change of SF-36(the MOS item short form health survey) after treatment and observation</measure>
    <time_frame>Baseline,26 weeks and 52 weeks</time_frame>
    <description>The investigator will use SF-36 to describe the health status of objects and compare the different change among different groups during observation period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the change of SAS(Self-Rating Anxiety Scale) and SDS(Self-rating Depression Scale) during observation period</measure>
    <time_frame>Baseline ,26weeks and 52 weeks</time_frame>
    <description>The investigator will use SAS and SDS to describe the anxiety status and depression status then compare the different change among different groups during observation period.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">554</enrollment>
  <condition>Heroin Addiction</condition>
  <arm_group>
    <arm_group_label>JITAI combined therapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigator will adopt JITAI combined psychological intervention and social support in Shanghai-related community.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methadone combined herapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigator will adopt JITAI combined psychological intervention and social support in Shanghai-related community.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>JITAI therapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigator will adopt JITAI combined social support in Shanghai-related community and outside of Shanghai.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>JITAI Combined with psychological intervention</intervention_name>
    <description>tablet，Each tablet weight 0.4g</description>
    <arm_group_label>JITAI combined therapy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
    <description>Oral Solution，1mg/ml</description>
    <arm_group_label>Methadone combined herapy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traditional Chinese Medicine JITAI</intervention_name>
    <description>tablet，Each tablet weight 0.4g</description>
    <arm_group_label>JITAI therapy group</arm_group_label>
    <other_name>JITAI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical Diagnosis of The opioid dependence

          -  After detoxification.

        Exclusion Criteria：

          -  Clinical Diagnosis of glaucoma and other severe mental disorder；

          -  serious organic disease within three months；

          -  can not comply with the test requirements；

          -  accept Hans therapy instrument；

          -  have tendence of suicide，self-injury and impulse；

          -  ECG abnormalities；

          -  ALT or AST greater than 5 times the upper limit of normal；

          -  history of epilepsy；

          -  Lactating or pregnant women，or women of childbearing age fails to take effective
             contraceptive measures；

          -  serious history of drug allergy or known allergy on traditional Chinese medicine
             JITAI；

          -  Study before the withdrawal less than a half-life of 5.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min ZHAO, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Mental Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute on Drug Dependence，Peking University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2012</study_first_submitted>
  <study_first_submitted_qc>April 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2012</study_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Mental Health Center</investigator_affiliation>
    <investigator_full_name>Min ZHAO</investigator_full_name>
    <investigator_title>vise president</investigator_title>
  </responsible_party>
  <keyword>the opioid dependence in rehabilitation phase</keyword>
  <keyword>community</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heroin Dependence</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methadone</mesh_term>
    <mesh_term>Heroin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

